Johnson & Johnson has stopped production of its single-dose COVID-19 vaccine

A member of the Philadelphia Hearth Division prepares a dose of the Johnson & Johnson COVID-19 vaccine at a vaccination website in Philadelphia on March 26, 2021. Johnson & Johnson has reportedly stopped the manufacturing of its single-dose COVID-19 vaccine.

Matt Rourke, Related Press

Johnson & Johnson has reportedly stopped the manufacturing of its single-dose COVID-19 vaccine, signaling that the corporate could in the reduction of on its general manufacturing of the vaccine.

The information:The New York Instances studies that Johnson & Johnson quietly shut down manufacturing at a plant within the Netherlands, which was the one location that was creating usable doses of the J&J COVID-19 vaccine.

Sure, however: “The power, within the Dutch metropolis of Leiden, has as a substitute been making an experimental however doubtlessly extra worthwhile vaccine to guard in opposition to an unrelated virus,” per The New York Instances

• The halt in manufacturing will final quickly, per The New York Instances.
• It’s unclear if the shutdown will impression general J&J vaccine provides as a result of there are stockpiles of the vaccine out there.

The opposite facet: J&J didn't verify the planet closure, however advised CBS Information that ”we at present have hundreds of thousands of doses of our COVID-19 vaccine in stock” and “we proceed to meet our contractual obligations ... (to) the African Union.”

One factor to observe: In October 2021, Johnson & Johnson stated it might commit about 50 million vaccines to COVAX, the worldwide initiative to offer vaccines all through the world, in response to The Hill.

• It’s unclear if the manufacturing shutdown would impression the distribution of these vaccines.